Kairos Ventures
Kairos Ventures invests in groundbreaking startups and research in life sciences, physical sciences, and technology, originating from the top minds of academia and industry. These technologies have the potential to make the world a better place.
📥 Buy Full VC Dataset
Offices: Beverly Hills (United States), Pasadena (United States), New York (United States), Washington D.C. (United States), Austin (United States)
Investment Stages: Seed, Series A, Series B
Markets: Life Sciences, Physical Sciences
Founded Year: 2015
Investor Type: Venture Capital
Portfolio Companies: 1200 Pharma, Actinia, Actuate Therapeutics, Amorphology, Avvio Medical, Axial Therapeutics, Behavioral Signals, Chimera Bioengineering, Clearsense, CytoDel, DEARhealth, Delpor, Foldax, GuRu, Holoclara, KMLabs, LifeSprout, Linnaeus, Mattiq, MemVerge, MidIR, MixComm, NanoClear Technologies, Neuro-Bio, nFugue, NVasc, Pomelo, Provivi, PteroDynamics, Quicksilver Biosciences, Sienza Energy, Specter Aerospace, Transient Plasma Systems (TPS), Vivodyne, Wonder Blades, Xidas
Website: https://www.kairosventures.com
Team Page: https://www.kairosventures.com/team/
Portfolio Link: https://www.kairosventures.com/portfolio/
LinkedIn: https://www.linkedin.com/company/kairos-venture-investments-llc.
Twitter: https://twitter.com/TweetKairosVC
Crunchbase: https://www.crunchbase.com/organization/kairos-venture-investments-llc
Pitchbook: https://pitchbook.com/profiles/investor/124408-36
Comments
No comments yet. Be the first to comment!